| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |